Aromatase inhibitors: past, present and future in breast cancer therapy-Reference-Cited by-同舟云学术

Aromatase inhibitors: past, present and future in breast cancer therapy

Published:2007-11-01 Issue:2 Volume:25 Page:113-124
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Dutta Udayan,Pant Kartikeya

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-007-9019-x.pdf

Reference110 articles.

1. ACS. American Cancer Society Breast Cancer Facts and Figures 1997–2007. http://www.cancer.org/docroot/STT/content/STT_1x_Cancer_Facts__Figures_2007.asp , Accessed October 17, 2007.

2. Boyd S. On oophorectomy in the treatment of cancer. Br Med J 1897;2:890–6.

3. Boyd S. Remarks on oophorectomy in treatment of cancer. Br Med J 1899;1:257–62.

4. Lemon HM. Abnormal estrogen metabolism and tissue estrogen receptor proteins in breast cancer. Cancer 1970;25:423–35.

5. Cutts JH. Estrogen-induced breast cancer in the rat. Proc Can Cancer Res Conf 1966;6:50–68.

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of tumor microenvironment on the different breast cancer subtypes and applied therapies;Biochemical Pharmacology;2024-05

2. Data driven analysis of aromatase inhibitors through machine learning, database mining and library generation;Chemical Physics;2024-01

3. Testolactone: The Rise and Fall of a Drug;Drugs and Drug Candidates;2023-02-04

4. Adjuvant endocrine therapy in patients with estrogen receptor-low positive breast cancer: A prospective cohort study;The Breast;2022-12

5. Single-digit nanomolar inhibitors lock the aromatase active site via a dualsteric targeting strategy;European Journal of Medicinal Chemistry;2022-12